Loading...
XSWX
CPHN
Market cap527mUSD
Dec 05, Last price  
70.80CHF
1D
0.57%
1Q
-3.54%
Jan 2017
77.00%
IPO
-5.91%
Name

CPH Chemie und Papier Holding AG

Chart & Performance

D1W1MN
XSWX:CPHN chart
P/E
91.30
P/S
0.95
EPS
0.78
Div Yield, %
42.37%
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
-3.12%
Revenues
448m
-28.23%
462,561,000507,758,000593,523,000570,358,000481,674,000417,396,000520,932,000488,691,000481,850,000492,817,000420,278,000437,546,000473,123,000537,391,000524,657,000445,189,000496,693,000725,351,000623,982,000447,857,000
Net income
5m
-94.11%
44,961,00049,464,00043,379,00030,596,00035,782,000-20,010,000-17,991,0008,061,000-271,480,00010,502,000-33,122,999-7,905,00015,983,00042,293,00048,341,00046,901,000-151,559,000100,953,00078,885,0004,648,000
CFO
46m
-58.42%
84,709,00088,929,00068,881,00082,331,000182,086,00079,445,000-13,808,00040,757,00031,409,00019,819,00023,313,00021,875,00032,189,99964,290,00061,027,00054,958,00015,833,00097,628,000109,862,00045,683,000
Dividend
Jun 25, 202426 CHF/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

CPH Chemie + Papier Holding AG, together with its subsidiaries, engages in developing, manufacturing, and distributing chemicals, printing paper, and pharmaceutical packaging films. The Chemistry division develops, manufactures, and distributes a range of molecular sieves, special zeolites, chromatography gels, and deuterated solvents under the Zeochem brand. The Paper division manufactures newsprint and magazine paper products under the Perlen Papier brand; and recycles domestically recovered paper. The Packaging division provides a range of PVC monofilms and coated PVdC high-barrier films for use in the pharmaceutical industry under the Perlen Packaging brand name. It operates in Switzerland, rest of Europe, the Americas, Asia, and internationally. The company was founded in 1818 and is headquartered in Root, Switzerland.
IPO date
Jun 11, 2001
Employees
1,184
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT